0000930413-11-002495.txt : 20110401 0000930413-11-002495.hdr.sgml : 20110401 20110401181239 ACCESSION NUMBER: 0000930413-11-002495 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110330 FILED AS OF DATE: 20110401 DATE AS OF CHANGE: 20110401 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HORAK IVAN D CENTRAL INDEX KEY: 0001247903 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-12957 FILM NUMBER: 11732981 MAIL ADDRESS: STREET 1: C/O IMMUNOMEDICS INC STREET 2: 300 AMERICAN ROD CITY: MORRIS PLAINS STATE: NJ ZIP: 07950 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ENZON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000727510 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 222372868 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 685 ROUTE 202/206 CITY: BRIDGEWATER STATE: NJ ZIP: 08807 BUSINESS PHONE: 908 541 8671 MAIL ADDRESS: STREET 1: 685 ROUTE 202/206 STREET 2: ATT: GENERAL COUNSEL CITY: BRIDGEWATER STATE: NJ ZIP: 08807 FORMER COMPANY: FORMER CONFORMED NAME: ENZON PHARMACEUTICALS INC DATE OF NAME CHANGE: 20021211 FORMER COMPANY: FORMER CONFORMED NAME: ENZON PHARMACEUTICAL INC DATE OF NAME CHANGE: 20021210 FORMER COMPANY: FORMER CONFORMED NAME: ENZON INC DATE OF NAME CHANGE: 19920703 4 1 c65039_4.xml X0303 4 2011-03-30 0 0000727510 ENZON PHARMACEUTICALS INC ENZN 0001247903 HORAK IVAN D C/O ENZON PHARMACEUTICALS, INC. 685 ROUTE 202/206 BRIDGEWATER NJ 08807 0 1 0 0 EVP, R&D, CSO Common Stock 2011-03-30 5 J 0 E 2500 A 122262 D Common Stock 2011-03-30 4 F 0 886 10.76 D 121376 D Shares acquired upon vesting of a portion of restricted stock units granted to the Reporting Person on September 22, 2010 and reported on a Form 4 filed on September 24, 2010. Vesting of 1/6 of the shares underlying the award was accelerated by the Board. The Reporting Person previously reported all restricted stock units granted to the Reporting Person on September 22, 2010 in Table I of the Form 4 filed on September 24, 2010. As such, no adjustment to the Reporting Person's beneficial ownership needs to be made to reflect this vesting event. Shares were withheld from the Reporting Person, in an exempt transaction under Rule 16b-3, solely to satisfy tax obligations arising from the vesting of the restricted stock units described in this Form 4. /s/ Andrew Rackear, Attorney-In-Fact 2011-04-01